POTASSIUM CITRATE
- Product NDC
- 70518-1221
- 11-digit product format
- 705181221
- Labeler code
- 70518
- Product ID
- 70518-1221_e336d41a-d8df-548d-e053-2a95a90a75dd
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- POTASSIUM CITRATE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA206813
- Marketing category
- ANDA
- Marketing start
- 2018-05-21
- Marketing end
- 0000-00-00
- Substance
- POTASSIUM CITRATE
- Active strength
- 10 meq/1
- Pharmacologic classes
- Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-1221-0 | 70518122100 | 100 TABLET in 1 BOTTLE, PLASTIC (70518-1221-0) | 100 tablet | 2018-05-21 | 0000-00-00 | No | No | Current |